A Philadelphia cell and gene therapy contract manufacturer is emerging from stealth mode with $64 million in funding, a custom-built facility at the Navy Yard and a veteran health care executive as its new CEO. 

VintaBio was founded in 2020 by Junwei Sun and Dr. Shangzhen Zhou, who developed the first viral vectors used for life-saving therapies, including the cell therapy that cured Children’s Hospital of Philadelphia patient Emily Whitehead of a pediatric cancer.

VintaBio is being led by newly appointed CEO David Radspinner, who spent nearly a decade overseeing global marketing and sales efforts at Cytiva, previously owned by GE Healthcare Life Sciences, and Thermo Fisher Scientific. He was most recently at Newark, Delaware-based ILC Dover, where he was president for the organization’s biotherapeutics portfolio.

*Article courtesy of Philadelphia Business Journal

For more information about Philadelphia medical space for sale or lease or about any other Philadelphia properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  medical commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical properties, industrial properties, land properties, retail buildings and other commercial properties for buyers, tenants, investors, and sellers.

Please visit our website for a full listing of Philadelphia commercial properties for sale or lease, www.wolfcre.com.